BioGaia AB (publ) (LON:0GTN)
London flag London · Delayed Price · Currency is GBP · Price in SEK
99.77
+0.05 (0.05%)
At close: Jul 28, 2025

BioGaia AB Company Description

BioGaia AB (publ), a healthcare company, develops, manufactures, markets and sells probiotic products for gut, oral, and immune health in Europe, the Middle East, Africa, the United States, the Asia-Pacific, Australia, and New Zealand.

It operates through Pediatrics, Adult Health, and Other segments. The Pediatrics segment offers drops, oral rehydration solutions, and gut health tablets, as well as cultures that are used as an ingredient in infant formula and milk formula.

The Adult Health segment provides gut health tablets, bone health tablets and oral health lozenges, as well as cultures, which are used as an ingredient in a licensee’s dairy product.

The Other segment provides packaging solutions. It sells its products through distribution partners or through its own distribution channels.

BioGaia AB (publ) was incorporated in 1990 and is based in Stockholm, Sweden.

BioGaia AB (publ)
CountrySweden
Founded1990
IndustryPharmaceutical Preparations
Employees225
CEOTheresa Agnew

Contact Details

Address:
Kungsbroplan 3
Stockholm, 112 27
Sweden
Phone46 8 55 52 93 00
Websitebiogaiagroup.com

Stock Details

Ticker Symbol0GTN
ExchangeLondon Stock Exchange
Share ClassClass B Shares
Fiscal YearJanuary - December
Reporting CurrencySEK
ISIN NumberSE0017769995
SIC Code2834

Key Executives

NamePosition
Theresa P. AgnewChief Executive Officer and President
Peter Rothschild M.Sc. Econ., MBAFounder and Chairman
Alexander Kotsinas M.Sc. (Eng.).Executive Vice President and Chief Financial Officer
Ludvig MilessonChief Operating Officer
Gianfranco GromponeChief Scentific Officer
Caroline MoforsExecutive Vice President and Chief Legal Officer
Linda HagglundChief Marketing Officer
Angelika KjelldorffChief Human Resources Officer
Sebastian HeimforsChief Commercial Officer
Jonathan GromarkSustainability Manager